Robert E. Landry, EVP Finance CFO at REGENERON PHARMACEUTICALS, INC. (REGN), sold 612 shares at $693.00 ($424K) on 2022-03-21, disclosed to the SEC on 2022-03-23.
Open-market sale of $424k REGN by EVP Finance CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $691.31 | 312 | $216K | 50.9% |
| 2 | $693.00 | 300 | $208K | 49.1% |
| Total | $692.14 avg | 612 | $424K | 100% |
| Filing → |
| REGN | SELL | 2023-08-25 | $188K | — | Filing → |
| REGN | SELL | 2023-03-29 | $1.8M | — | Filing → |
| REGN | SELL | 2023-02-07 | $2.1M | — | Filing → |